Showing results (411-420 of 437) with videos related to
Sort By:
Pageof 44
Molecular Cancer Therapeutics|July 11, 2007
The HLA A*0201-restricted hTERT(540-548) peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptorMarco A Purbhoo, Yi Li, Deborah H Sutton, et al.Plos One|April 25, 2015
A Maltose-Binding Protein Fusion Construct Yields a Robust Crystallography Platform for MCL1Matthew C Clifton, David M Dranow, Alison Leed, et al.Frontiers in Plant Science|June 15, 2017
Environmental Influences on the Growing Season Duration and Ripening of Diverse Miscanthus Germplasm Grown in Six CountriesChristopher Nunn, Astley Francis St John Hastings, Olena Kalinina, et al.Vaccine|September 12, 2019
MomsTalkShots: An individually tailored educational application for maternal and infant vaccinesDaniel A Salmon, Rupali J Limaye, Matthew Z Dudley, et al.Cancer Journal (Sudbury, Mass.)|May 15, 2002
Intensity-modulated radiotherapySteven A Leibel, Zvi Fuks, Michael J Zelefsky, et al.BMC Public Health|November 21, 2022
MomsTalkShots, tailored educational app, improves vaccine attitudes: a randomized controlled trialMatthew Z Dudley, Saad B Omer, Sean T O'Leary, et al.Frontiers in Plant Science|October 18, 2019
Factors Affecting Targeted Sequencing of 353 Nuclear Genes From Herbarium Specimens Spanning the Diversity of AngiospermsGrace E Brewer, James J Clarkson, Olivier Maurin, et al.Journal of Medicinal Chemistry|March 18, 2015
Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine CarbapenemasesScott J Hecker, K Raja Reddy, Maxim Totrov, et al.Protein & Cell|January 8, 2011
High affinity soluble ILT2 receptor: a potent inhibitor of CD8(+) T cell activationRuth K Moysey, Yi Li, Samantha J Paston, et al.Blood|November 14, 2022
NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenograftsDeyi Zhang, Hailey M Harris, Jonathan Chen, et al.Pageof 44